Literature DB >> 12642463

Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals.

Khawja A Usmani1, Randy L Rose, Ernest Hodgson.   

Abstract

Cytochrome P450 (P450) enzymes are major catalysts involved in the metabolism of xenobiotics and endogenous substrates such as testosterone (TST). Major TST metabolites formed by human liver microsomes include 6beta-hydroxytestosterone (6beta-OHTST), 2beta-hydroxytestosterone (2beta-OHTST), and 15beta-hydroxytestosterone (15beta-OHTST). A screen of 16 cDNA-expressed human P450 isoforms demonstrated that 94% of all TST metabolites are produced by members of the CYP3A subfamily with 6beta-OHTST accounting for 86% of all TST metabolites. Similar K(m) values were observed for production of 6beta-, 2beta-, and 15beta-OHTST with human liver microsomes (HLM) and CYP3A4. However, V(max) and CL(int) were significantly higher for 6beta-OHTST than 2beta-OHTST (approximately 18-fold) and 15beta-OHTST (approximately 40-fold). Preincubation of HLM with a variety of ligands, including chemicals used in military deployments, resulted in varying levels of inhibition or activation of TST metabolism. The greatest inhibition of TST metabolism in HLM was following preincubation with organophosphorus compounds, including chlorpyrifos, phorate, and fonofos, with up to 80% inhibition noticed for several metabolites including 6beta-OHTST. Preincubation of CYP3A4 with chlorpyrifos, but not chlorpyrifos-oxon, resulted in 98% inhibition of TST metabolism. Phorate and fonofos also inhibited the production of most primary metabolites of CYP3A4. Kinetic analysis indicated that chlorpyrifos was one of the most potent inhibitors of major TST metabolites followed by fonofos and phorate. Chlorpyrifos, fonofos, and phorate inhibited major TST metabolites noncompetitively and irreversibly. Conversely, preincubation of CYP3A4 with pyridostigmine bromide increased metabolite levels of 6beta-OHTST and 2beta-OHTST. Preincubation of human aromatase (CYP19) with the test chemicals had no effect on the production of the endogenous estrogen, 17beta-estradiol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642463     DOI: 10.1124/dmd.31.4.384

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study.

Authors:  Catherine C Lerro; Stella Koutros; Gabriella Andreotti; Melissa C Friesen; Michael C Alavanja; Aaron Blair; Jane A Hoppin; Dale P Sandler; Jay H Lubin; Xiaomei Ma; Yawei Zhang; Laura E Beane Freeman
Journal:  Occup Environ Med       Date:  2015-07-06       Impact factor: 4.402

2.  Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice.

Authors:  Ying Guo; Chad Pope; Xingguo Cheng; Honghao Zhou; Curtis D Klaassen
Journal:  J Ethnopharmacol       Date:  2011-09-06       Impact factor: 4.360

Review 3.  Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Dan-Ping Hu; Jason L Nelles; Gail S Prins
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

4.  Does thyroid disruption contribute to the developmental neurotoxicity of chlorpyrifos?

Authors:  Theodore A Slotkin; Ellen M Cooper; Heather M Stapleton; Frederic J Seidler
Journal:  Environ Toxicol Pharmacol       Date:  2013-04-21       Impact factor: 4.860

Review 5.  Endocrine disruptors and prostate cancer risk.

Authors:  Gail S Prins
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

Review 6.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

7.  Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.

Authors:  Robin E Pearce; Wei Lu; Yongqiang Wang; Jack P Uetrecht; Maria Almira Correia; J Steven Leeder
Journal:  Drug Metab Dispos       Date:  2008-05-07       Impact factor: 3.922

8.  Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study.

Authors:  Stella Koutros; Laura E Beane Freeman; Jay H Lubin; Sonya L Heltshe; Gabriella Andreotti; Kathryn Hughes Barry; Curt T DellaValle; Jane A Hoppin; Dale P Sandler; Charles F Lynch; Aaron Blair; Michael C R Alavanja
Journal:  Am J Epidemiol       Date:  2012-11-21       Impact factor: 4.897

Review 9.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

10.  Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS).

Authors:  Carol H Christensen; Elizabeth A Platz; Gabriella Andreotti; Aaron Blair; Jane A Hoppin; Stella Koutros; Charles F Lynch; Dale P Sandler; Michael C R Alavanja
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.